XVI Workshop on Neurobiology of Epilepsy (WONOEP 2022)

Early onset epilepsies: neurobiology and novel therapeutic strategies

Talloires, France

4 - 8 July 2022

WONOEP XVI, a satellite event of the 14th ILAE European Epilepsy Congress, will take place at Talloires, France. The main topic of WONOEP XVI is “Early onset epilepsies: neurobiology and novel therapeutic strategies”. The overall purpose of WONOEP XVI will be to provide novel insights on early onset epilepsies, underlying neurobiology and strategies towards the development of new treatments.

This will include novel insights into brain development, and how its dysfunction may lead to epilepsy and its comorbidities; the role of genetic factors, in particular somatic mosaicism, in focal malformations of cortical development; the discussion on relevant disease models, including brain organoids and experimental models, and their contribution to a better understanding of developmental epileptogenic processes; the development of improved diagnostic tools for the localization of the epileptogenic zone in structural epilepsies; novel therapeutic strategies for precision treatments. Both preclinical and clinical studies will be considered.

Participants in this face-to-face workshop will be limited to individuals who are fully and up-to-date vaccinated for COVID-19 with eligible vaccines and according to the following guidelines:

Abstracts: Submissions are now closed. Those who submitted abstracts will be contacted in late March 2022 with their results.

WONOEP 2022 is organized by the WONOEP Task Force of the ILAE Neurobiology Commission and the Neurobiology Commission of the ILAE. WONEP is generously supported by a donation of the Harinarayan Family.

Scientific Organizing Committee: Stéphane Auvin, Stéphanie Baulac, Aristea S. Galanopoulou, Terence O’Brien, David Henshall, Özlem Akman, Raman Sankar

For WONOEP queries please contact: wonoep@ilae.org


ILAE wishes to acknowledge the support to WONOEP 2022 provided through an educational grant from Jazz Pharmaceuticals.

Jazz Pharmaceuticals Logo

Please note that the company have had no direct or indirect influence on the composition of the series or the content. ILAE is solely responsible for the creation and control of the series content.